Real World Diagnosis and Treatment Outcomes in Patients with EGFR-Mutant Metastatic Lung Cancer

被引：0
作者：
Li, T. [1 ]
Ma, W. [1 ]
Tian, E. [1 ]
Li, Q. [1 ]
机构：
[1] Univ Calif Davis, Comprehens Canc Ctr, Div Hematol Oncol, Internal Med, Sacramento, CA 95817 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
EGFR-mutant lung cancer; treatment outcome; Survival;
D O I：
10.1016/j.jtho.2019.08.2371
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.16-06
引用
收藏
页码：S1066 / S1067
页数：2
相关论文
共 50 条
[41]   Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients [J].
Ruglioni, Martina ;
Petrini, Iacopo ;
Crucitta, Stefania ;
Sbrana, Andrea ;
Luculli, Giovanna Irene ;
Gol, Leila Sadeghi ;
Forte, Carola ;
Chella, Antonio ;
Rolfo, Christian ;
Danesi, Romano ;
Del Re, Marzia .
TRANSLATIONAL ONCOLOGY, 2025, 52
[42]   Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer [J].
Cramer-van der Welle, Christine M. ;
Schramel, Franz M. N. H. ;
van Leeuwen, Arvid S. ;
Groen, Harry J. M. ;
van de Garde, Ewoudt M. W. .
EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (05)
[43]   Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib [J].
Wu, Jia-Jun ;
Tseng, Jeng-Sen ;
Zheng, Zhe-Rong ;
Chu, Cheng-Hsiang ;
Chen, Kun-Chieh ;
Lin, Mong-Wei ;
Huang, Yen-Hsiang ;
Hsu, Kuo-Hsuan ;
Yang, Tsung-Ying ;
Yu, Sung-Liang ;
Chen, Jin-Shing ;
Ho, Chao-Chi ;
Chang, Gee-Chen .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[44]   Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status [J].
Travers, Avraham ;
Jalali, Azim ;
Begbie, Stephen ;
Semira, Christine ;
Kosmider, Suzanne ;
Ananda, Sumitra ;
Wong, Rachel ;
Lee, Margaret ;
Shapiro, Jeremy ;
Burge, Matthew ;
Yip, Desmond ;
Torres, Javier ;
Ma, Brigette ;
Nott, Louise ;
Dean, Andrew ;
Tie, Jeanne ;
Khattak, Adnan ;
Lim, Stephanie ;
Wong, Hui-li ;
Gibbs, Peter .
CLINICAL COLORECTAL CANCER, 2021, 20 (01) :E21-E34
[45]   Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis [J].
Yoshimura, Akihiro ;
Yamada, Tadaaki ;
Tsuji, Taisuke ;
Hamashima, Ryosuke ;
Shiotsu, Shinsuke ;
Yuba, Tatsuya ;
Takumi, Chieko ;
Uchino, Junji ;
Hiraoka, Noriya ;
Takayama, Koichi .
THORACIC CANCER, 2019, 10 (03) :557-563
[46]   Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis [J].
Gen, Soei ;
Tanaka, Ichidai ;
Morise, Masahiro ;
Koyama, Junji ;
Kodama, Yuta ;
Matsui, Akira ;
Miyazawa, Ayako ;
Hase, Tetsunari ;
Hibino, Yoshitaka ;
Yokoyama, Toshihiko ;
Kimura, Tomoki ;
Yoshida, Norio ;
Sato, Mitsuo ;
Hashimoto, Naozumi .
BMC CANCER, 2022, 22 (01)
[47]   Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells [J].
Gao, Wen ;
Wang, Michael ;
Wang, Li ;
Lu, Haibo ;
Wu, Shuhong ;
Dai, Bingbing ;
Ou, Zhishuo ;
Zhang, Liang ;
Heymach, John V. ;
Gold, Kathryn A. ;
Minna, John ;
Roth, Jack A. ;
Hofstetter, Wayne L. ;
Swisher, Stephen G. ;
Fang, Bingliang .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09)
[48]   A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms [J].
Rivera-Concepcion, Joel ;
Lo, Ying-Chun ;
Uprety, Dipesh ;
Adjei, Alex A. ;
Ernani, Vinicius ;
Leventakos, Konstantinos .
CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 13
[49]   Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer? [J].
Kulkarni, Amit A. ;
Naqash, Abdul Rafeh ;
Puri, Sonam ;
Dienstmann, Rodrigo .
JCO PRECISION ONCOLOGY, 2021, 5 :408-414
[50]   Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis [J].
Sasaki, Takashi ;
Kanata, Ryo ;
Yamada, Ikuhiro ;
Matsuyama, Masato ;
Ozaka, Masato ;
Sasahira, Naoki .
IN VIVO, 2019, 33 (01) :271-276
12345